Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 8,479,000 | 8,255,000 | 7,828,000 | 8,305,000 | 8,236,000 |
| Cost of Goods | 1,920,000 | 1,819,000 | 1,694,000 | 2,022,000 | 1,835,000 |
| Gross Profit | 6,559,000 | 6,436,000 | 6,134,000 | 6,283,000 | 6,401,000 |
| Operating Expenses | 3,942,000 | 3,036,000 | 3,124,000 | 8,724,000 | 3,242,000 |
| Operating Income | 2,617,000 | 3,400,000 | 3,010,000 | -2,441,000 | 3,159,000 |
| Interest Expense | 420,000 | 309,000 | 325,000 | 319,000 | 302,000 |
| Other Income | -196,000 | -2,284,000 | -141,000 | 387,000 | -96,000 |
| Pre-tax Income | 2,001,000 | 807,000 | 2,544,000 | -2,373,000 | 2,761,000 |
| Income Tax | 117,000 | 66,000 | 88,000 | -547,000 | 14,000 |
| Net Income Continuous | 1,884,000 | 741,000 | 2,456,000 | -1,826,000 | 2,747,000 |
| Net Income | $1,884,000 | $741,000 | $2,456,000 | $-1,826,000 | $2,747,000 |
| EPS Basic Total Ops | 1.27 | 0.49 | 1.65 | -1.14 | 1.81 |
| EPS Basic Continuous Ops | 1.27 | 0.50 | 1.66 | -1.14 | 1.82 |
| EPS Diluted Total Ops | 1.26 | 0.49 | 1.65 | -1.15 | 1.81 |
| EPS Diluted Continuous Ops | 1.27 | 0.50 | 1.66 | -1.14 | 1.81 |
| EBITDA(a) | $3,120,000 | $3,902,000 | $3,513,000 | $-1,999,000 | $3,594,000 |